It is a pharma public limited company based in Chandigrah, Chandigarh, India, established in 1991.
1991 | Chandigrah, Chandigarh, India | ActiveHindustan Drugs Limited, a active public limited company, was established on 11 January 1991 in Chandigrah, Chandigarh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231CH1991PLC010976. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Jaspal Singh (Director), Harman Singh (Director), Jasneet Kaur (Director). Past directors included Ranbir Singh Sodhi, Jasneet Kaur, Ramachandra Moorty Sistla. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House No. 2412 Sec-37 C, Chandigrah, Chandigarh, 160036.
U24231CH1991PLC010976
010976
11 January 1991
₹1.00 Cr
₹0.50 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Hindustan Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jaspal Singh | Director | 11 Jan 1991 | Current |
| Harman Singh | Director | 02 Jan 2006 | Current |
| Jasneet Kaur | Director | 14 Oct 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Oct 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 27 Sep 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hindustan Drugs Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 23.57% decrease in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
In 2023, Hindustan Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Hindustan Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hindustan Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hindustan Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Hindustan Drugs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Hindustan Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was recorded as a recent event.
Progress on Jasneet Kaur was appointed as a Director was appointed as a Director on 14 Oct 2014 & has been associated with this company since 11 years 1 month . was documented.
Harman Singh was appointed as a Director was appointed as a Director on 02 Jan 2006 & has been associated with this company since 19 years 10 months . was recorded as a recent event.
Progress on Jaspal Singh was appointed as a Director was appointed as a Director on 11 Jan 1991 & has been associated with this company since 34 years 10 months . was documented.
Hindustan Drugs Limited was registered on 11 Jan 1991 with Roc Chandigarh & aged 34 years 10 months as per MCA records. was recorded as a recent event.
The CIN of Hindustan Drugs Limited is U24231CH1991PLC010976.
Hindustan Drugs Limited is headquartered at House No. 2412 Sec-37 C, Chandigrah, Chandigarh, 160036.
Hindustan Drugs Limited was incorporated on 11 January 1991.
The current directors of Hindustan Drugs Limited are
The primary industry of Hindustan Drugs Limited is Manufacturing.
Hindustan Drugs Limited is unlisted.
The authorized capital of Hindustan Drugs Limited is ₹1.00 Cr, and the paid-up capital is ₹0.50 M.
The compliance status of Hindustan Drugs Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX